Rule 8 Alltracel Pharmaceutic

RNS Number:7750M
Appian Wealth Management
29 January 2008

FORM 8.1/8.3



IRISH TAKEOVER PANEL



Lodge with the Stock Exchange (which may publicise) and with the Panel.

Use separate form for each class of securities in which dealings have been made.



Date of disclosure......28th January 2008......................



DISCLOSURE UNDER RULE 8.1(a), 8.1(b)(i) and 8.3 OF THE IRISH

TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2001



Date of Dealing ............................................23rd January 2008...
..............................................



Dealing in (name of company).......................Alltracel Pharmaceuticals
plc..............................



(1) Class of securities (e.g. ordinary shares)  ....Ordinary shares



(2)


Amount Bought              Amount Sold        Price per Unit
50,000                                        0.110                GBP





(3) Resultant total of the same class owned or controlled   10,130,296

(and percentage of class)     .............................................
....7.1%



(4) Party making disclosure..................Appian Wealth
Management.........................



(5) EITHER (a) Name of purchaser/vendor (Note 1)

OR (b) If dealing for discretionary client(s), name of fund

management organization



Appian Wealth Management

........................................................................................................................
.......................



(6) Reason for disclosure (Note 2)

(a) (i) offeror or associate of offeror (Note 3)                        NO



(ii) offeree or associate of offeree                                    NO



Specify which category or categories of associate ((a) to (l) page 3/4)



If category (l), explain
........................................................................................................................
......



(b) Rule 8.3 (i.e. disclosure because of ownership or control of 1% or more the
class of

relevant securities dealt in)                                     YES





Signed, for and on behalf of the party named in (4) above



 ..................................................................





Anne Chambers



Telephone and extension number..........................01 6623981


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

ISEEAAFNADLPEFE

Alltracel Pharmaceuticals (LSE:AP.)
過去株価チャート
から 4 2024 まで 5 2024